Endothelin exhibits vascular bed and large vein selectivity, causing differential regional blood flow responses compared to angiotensin II.
Answers are grounded in this paper and cite their sources.
Rabbit data on endothelin selectivity do not inform therapy; leaves open its human vascular bed effects.
Endothelin (Et), a vasoconstrictor peptide, was 5-10-fold more potent (lower EC50) on isolated ring segments of large veins than on large arteries removed from dog coronary, mesenteric, femoral, renal and internal mammary vasculature and from the human internal mammary pedicle. 2. In the dog large coronary artery, Et (10-30 nmol/L) caused transient relaxations partway through the generation of a concentration-contraction curve. These relaxations were endothelium dependent. 3. In conscious rabbits treated with mecamylamine, Et (0.025-0.4 nmol/kg) caused a marked rise in renal vascular resistance but hindquarter vasodilation. Under the same conditions angiotensin II constricted both beds. 4. These studies suggest that Et is vascular bed and large vein selective in activity. It did not appear to be selective for large or small coronary arteries in vitro.
No takes yet. Share an insight, caveat, or question.
Cocks et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: